Selank

Also known as: TP-7, Thr-Lys-Pro-Arg-Pro-Gly-Pro, Tuftsin analogue

Tuftsin-derived anxiolytic peptide that modulates GABA and raises BDNF and NGF, easing anxiety without sedation or dependence. Typically dosed intranasally. A prescription anxiolytic in Russia, not FDA-approved.

Pharmacokinetics

Research only · no verified human PK. The values below are class estimates, not measured data, and this peptide is excluded from the Lab serum-level simulator.

Half-life: 3 min
Time to peak: 15 min
Bioavailability: 80%
Onset: 30 min
Dosing interval: 8h

Administration

Primary routes: Intranasal, SubQ
Category: Neurological

Safety Flags

High immunogenicity
Contraindicated in cancer history

Storage

· Requires refrigeration (2–8°C)
· Temperature sensitive — minimise room-temp exposure

Used in 4 outcome protocols

Simulate Selank

Pinned.life runs a 1-compartment Bateman pharmacokinetic simulation against 38 peptides in real time. Build a stack, see serum-level curves, get warned about peak overlaps and drug-peptide interactions.

Open the Lab →How the PK engine works